NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 7.05% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.55% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.38% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.11% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.01% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.80% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.72% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.56% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.48% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.45% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.45% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.41% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.04% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |